Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 353-363, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paterson, A. R. P.
Right arrow Articles by Simpson, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paterson, A. R. P.
Right arrow Articles by Simpson, A. I.

Inhibitors of Nucleoside Metabolism1

A. R. P. Paterson and A. I. Simpson2

A group of 143 compounds, consisting mainly of substituted purines, was tested as potential inhibitors of ribonucleoside metabolism; the screening system was the synthesis of inosine, in vitro, by erythrocytes from humans. A series of purine derivatives with particular substituent groups at positions 6 and 9 inhibited inosine synthesis by intact erythrocytes, but these compounds had no effect against the same reaction catalyzed by disrupted erythrocytes. Compounds that were inhibitory in the erythrocyte system also inhibited the uridine-supported synthesis of inosine by intact Ehrlich ascites tumor cells. The most effective inhibitors were 6-thioether derivatives of purine ribonucleoside or 2-aminopurine ribonucleoside.

1 This investigation was supported by the Medical Research Council of Canada and by the National Cancer Institute of Canada.

2 University of Alberta Cancer Research Unit (McEachern Laboratory) and Department of Biochemistry, Edmonton, Alberta.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.